Contraceptives Market is forecast to reach a value of US$ 37,889.0 Mn by 2028 at a CAGR of 5.5% between 2021 and 2028

Contraceptives are used after sex to prevent pregnancy. There are two types of emergency contraception: ECPs and copper T intrauterine devices (IUD).

Statistics:

The global contraceptives market is expected to be worth US$ 25,969.2 million in 2020, rising to US$ 37,889.0 million by 2027.

Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/365

Global Contraceptives Market: Drivers

The global emergency contraceptives market is expected to grow at a fast pace during the forecast period due to the rising population. For instance, according to Population Reference Bureau (PRB) estimates published in the 2018 World Population Data Sheet, the global population is expected to grow to 9.9 billion by 2050, an increase of 2.3 billion or 29 % from an average of 7.6 billion in 2018.

Furthermore, the increasing emphasis on family planning among the public is expected to boost the global contraceptive market growth over the forecast period. According to the PRB’s 2019 Family Planning Data Sheet, 62 % of married women of age 15 to 49 years use a form of family planning, with 56 % using a modern approach.

In 2019, the devices segment accounted for the largest share in the global contraceptive market, representing 57.2 % of the market share, trailed by drugs.

Global Contraceptives Market: Restraints

The adverse effects of contraceptive drugs and devices are expected to hamper the global contraceptive market’s growth. Long-term negative effects of oral contraceptive drugs, such as a high risk of breast cancer, heart attacks, and blood clots, strongly discourage their use.

Furthermore, poor uptake of emergency contraception in developing nations is expected to hamper the global contraceptive market growth over the forecast period. For instance, according to PRB’s 2019 Family Planning Data Sheet, less than 15% of married women of reproductive age in the Democratic Republic of the Congo use advanced contraceptives.

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/365

Global Contraceptives Market: Opportunities

The growing literacy rate is expected to provide lucrative growth possibilities for companies in the global contraceptive market. According to the United Nations Children’s Fund, the global youth literacy rate improved from 83 % to 91 % between 1985 and 2018.

Furthermore, the rising incidence of HIV/AIDS is expected to increase the demand for contraceptives. According to the UNAIDS Global HIV & AIDS statistics — 2019 fact sheet, 37.9 million individuals worldwide are infected with HIV.

The global contraceptives market was worth US$ 24,605.4 million in 2019 and is expected to grow US$ 37,889.0 million by 2027, growing at a CAGR of 5.5 % during the forecast period 2020 – 2027.

Market Trends/Key Takeaways

Major contraceptive drugs are reaching patent expiration, which will allow generics to enter the market. For instance, the patent on YAZ (ethinylestradiol/ drospirenone), an oral contraceptive regimen, is expected to expire in 2021.

Key market players are concentrating on the approval and introduction of new products in order to grow their product offerings. For instance, Agile Therapeutics, Inc. obtained U.S. Food and Drug Administration (FDA) approval in February 2020 for its Twirla (Ethinyl estradiol and levonorgestrel) transdermal system recommended as a form of contraception for use in women.

Global Contraceptives Market: Competitive Landscape

Some of the key players contributing to the global emergency contraceptives market are BioSante Pharmaceuticals Inc., Perrigo Company plc, Mankind Pharma, Uniprix, Agile Therapeutics Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Pantarhei Bioscience B.V., Sandoz International GmbH, Merck & Co, Sun Pharmaceutical Industries Ltd., Allergan, Aurobindo Pharma Limited, Mayer Laboratories, Inc., Gavis Pharmaceuticals (Lupin Limited), Pfizer, Inc., HRA Pharma, Church & Dwight, Co. Inc., Evofem Biosciences, Inc., SA, and Bayer HealthCare AG.

Global Contraceptives Market: Key Developments

The market’s key players are concentrating their efforts on raising capital in order to increase their product line. For instance, Evofem Biosciences, Inc. in April 2020 signed a private Securities Purchase Agreement with a healthcare-focused institutional investor in the U.S. for around US$ 25 million in convertible bonds.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/365

Reasons to Purchase this Report

• Current and future of global Contraceptives Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations

Table of Contents

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Type
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Technological Advancement
   • Regulatory Scenario
4. Global Contraceptives Market, By Type, 2017 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2019–2027
     • Segment Trends
   • Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
     • Segment Trends
       • Oral Contraceptive Pills
       • Injectables
       • Topical
   • Devices
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
     • Segment Trends
       • Male Condoms
       • Female Condoms
       • Diaphragms
       • Sponges
       • Vaginal Rings
       • Subdermal Implants
       • IUD
5. Global Contraceptives Market, By Regions, 2017 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2019–2027
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
       • North Africa
       • Central Africa
       • South Africa